Related Experiment Video
Updated: Jun 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Endoscopic Submucosal Dissection-Associated Bacteremia: Proper Antibiotic Management
Wenhui Xia1, Yuxuan Chen1, Jianyu Lv2
1The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Endoscopic submucosal dissection (ESD) is a valuable treatment for early GI cancers but carries a low risk of bacteremia. This review examines bacteremia risks and antibiotic necessity after ESD procedures.
Area of Science:
- Gastroenterology
- Endoscopy
- Infectious Disease
Background:
- Endoscopic submucosal dissection (ESD) effectively treats early gastrointestinal cancers and precancerous lesions.
- ESD's complexity can lead to complications like perforation, increasing bacteremia risk.
- Bacteremia post-ESD is generally low (<5%), transient, and rarely causes severe infections.
Purpose of the Study:
- To analyze the risk of bacteremia following ESD across various digestive tract locations.
- To evaluate the necessity of antibiotic prophylaxis for ESD procedures.
- To provide a clinical reference for managing bacteremia risk in ESD.
Main Methods:
- Systematic literature search of PubMed, Embase, and Cochrane Library.
- Analysis of studies published up to January 2026.
- Narrative review focusing on bacteremia incidence and outcomes after ESD.
Main Results:
- The overall incidence of bacteremia after ESD is low.
- Bacteremia is typically transient and asymptomatic.
- Perforation during ESD increases the risk of bacteremia and potential complications.
Conclusions:
- While bacteremia after ESD is uncommon, understanding its risks is crucial.
- Further research is needed to define optimal antibiotic strategies.
- ESD remains a valuable endoscopic intervention with manageable complication risks.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Microbiota Modulation by Antibiotics
Endocarditis III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...